Vimarsana
Biggest News Aggregation in the World

Page 35 - Genuity Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genuity Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genuity Group Today - Breaking & Trending Today

Base Resources (LON:BSE) Hits New 1-Year High at $15.00 - Vimarsana News

Base Resources (LON:BSE) Hits New 1-Year High at $15.00

Shares of Base Resources Limited (LON:BSE – Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as GBX 15 ($0.19) and last traded at GBX 14.70 ($0.19), with a volume of 197426 shares changing hands. The stock had previously closed at GBX 14.98 ($0.19). Wall Street […]

Source: wkrb13.com
Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Up 8.2% - Vimarsana News

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Up 8.2%

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price rose 8.2% during mid-day trading on Monday . The company traded as high as $39.03 and last traded at $38.61. Approximately 174,823 shares were traded during trading, a decline of 71% from the average daily volume of 604,009 shares. The stock had previously closed at […]

Capital Research Global Investors Buys 279 Shares of Penumbra, Inc. (NYSE:PEN) - Vimarsana News

Capital Research Global Investors Buys 279 Shares of Penumbra, Inc. (NYSE:PEN)

Capital Research Global Investors raised its stake in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 0.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,677,789 shares of the company’s stock after purchasing an additional 279 shares during the period. Capital Research […]

Source: wkrb13.com
Smartsheet (NYSE:SMAR) Issues Q2 Earnings Guidance - Vimarsana News

Smartsheet (NYSE:SMAR) Issues Q2 Earnings Guidance

Smartsheet (NYSE:SMAR – Get Free Report) updated its second quarter earnings guidance on Wednesday. The company provided EPS guidance of $0.28-$0.29 for the period, compared to the consensus EPS estimate of $0.25. The company issued revenue guidance of $273-$275 million, compared to the consensus revenue estimate of $273.77 million. Smartsheet also updated its FY25 guidance […]

Capital World Investors Has $1.15 Billion Position in DexCom, Inc. (NASDAQ:DXCM) - Vimarsana News

Capital World Investors Has $1.15 Billion Position in DexCom, Inc. (NASDAQ:DXCM)

Capital World Investors lifted its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 130.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,278,685 shares of the medical device company’s stock after acquiring an additional 5,256,092 shares during […]